Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index; none of the 105 sources its claims cite is checked for support yet.
Abstract
Onset of many neurodegenerative and neuromuscular diseases usually starts in adulthood; however, recent advances point towards neurodevelopmental changes as drivers of late neurodegeneration. How early neuropathological features occur under these conditions remains unclear, but this knowledge would be critical for timely therapeutic intervention. Here, we provide evidence that neurodevelopmental axonal defects initiate a motor phenotype in a zebrafish model of spinocerebellar ataxia type 37 (SCA37), a degenerative hereditary disease caused by an ATTTC repeat in the DAB1 gene. We investigated neuronal defects triggered by the embryonic AUUUC repeat RNA from the DAB1 gene and their effects later in life by transiently expressing this RNA in embryos and analyzing innervation and motor function. We found abnormalities in motor neuron axonal outgrowth and muscle innervation. We also discovered disrupted embryonic motor activity, and reduced locomotor distance and velocity in late adult zebrafish, demonstrating motor impairment. Moreover, we showed that protein expression of the splicing regulator NOVA2 rescues axonal defects, indicating dysfunction of NOVA2-regulated neurodevelopmental processes. Overall, our results establish embryonic expression of the AUUUC repeat RNA as a driver of axonal and synaptic abnormalities, interfering with neuronal circuits and culminating in adult motor dysfunction.
Overview
CoChat Summary
TL;DR
Transient embryonic expression of the SCA37-associated (AUUUC)58 repeat RNA in zebrafish causes axonal and neuromuscular developmental defects and later adult motor impairment. NOVA2 co-expression partially rescues the axonal phenotype, implicating NOVA2 loss-of-function in SCA37.
Key findings
- Pathogenic (AUUUC)58 RNA microinjection increased 24 hpf lethality/morphological defects (77±21% vs 33±12% for non-pathogenic (AUUUU)7 and 25±13% for vehicle; P<0.0001), reduced survival (25% vs 55%/56%) and hatching (37% vs 74%/78%) by 96 hpf (P<0.0001).
- It shortened primary motor neuron axons at 24 hpf (27±8 µm vs 43±12 µm for (AUUUU)7, P=0.0003; vs 40±11 µm for vehicle, P=0.004), reduced dorsal/ventral AChR distribution and AChR cluster area, and decreased α-BTX intensity at 72 hpf (1475±1403 vs 2559±1678 a.u. for (AUUUU)7, P=0.034).
- It increased spontaneous tail coiling at 24 hpf (5±6 vs 3±2 coils; P=0.043 vs (AUUUU)7, P=0.003 vs vehicle) and caused late-adult motor impairment at 17 months (swimming distance 28±9 m vs 39±11 m, P=0.001; speed 9±2 vs 12±3 cm/s, P=0.0005 vs (AUUUU)7), without significant Purkinje cell differentiation defects at 120 hpf.
- Human NOVA2 co-microinjection partially rescued PMN axon length [(AUUUC)58: 31±8 µm; (AUUUC)58+NOVA2: 37±8 µm, P=0.01]; nova2 knockdown shortened axons (24±6 µm vs vehicle 31±7 µm, P=0.00006; control MO 31±5 µm, P=0.0001), partially rescued by human NOVA2 (28±7 µm, P=0.03). RBPmap identified NOVA1 as the only database RBP with higher affinity for pathogenic RNA, with 61 predicted NOVA1 binding sites in (AUUUC)58 vs 3 in (AUUUU)199.
Methods
- Zebrafish embryos were microinjected at the one- to two-cell stage with ~5 nl in vitro transcribed RNAs at 100 ng/µl: non-pathogenic (AUUUU)7, large non-pathogenic (AUUUU)139, pathogenic (AUUUC)58, or vehicle; GFP mRNA was co-injected to assess microinjection efficiency, and embryos were scored at 24–26 hpf and raised for later analyses.
- Developmental and behavioral assays included survival/hatching from 0–96 hpf, morphology scoring (0–3), RT-PCR for RNA integrity, whole-mount immunofluorescence for SV2, α-bungarotoxin, and zebrin II, confocal imaging and axon tracing, spontaneous tail coiling at 24 hpf, touch-evoked escape at 72 hpf, spontaneous locomotor activity at 144 hpf, and novel diving tank tests at 3 and 17 months.
- Mechanistic experiments used RBPmap in silico prediction, human NOVA2 mRNA co-microinjection with anti-histidine validation, and nova2 morpholino knockdown with RT-PCR validation of Nova2 target splicing (Dock6, Rap1Gap, DBS/MCF2L, Neo1); statistical analyses used ANOVA, Kruskal–Wallis, log-rank, and related post-hoc tests.
Limitations
- Stated: the NOVA2 rescue was performed only in PMNs at 24 hpf, axon lengths did not completely return to control levels, and rescue of the adult motor phenotype was not tested.
- Stated: zebrafish Nova2 and human NOVA2 are not functionally equivalent, as human NOVA2 did not rescue Rap1Gap, DBS (MCF2L), or Neo1 splicing defects after nova2 morpholino; the microinjection model is transient and does not cover sustained DAB1 upregulation found in patient-derived neurons.
- Evident from the text: findings are in zebrafish using microinjected human repeat RNA, with no human fetal or patient validation; only one pathogenic repeat length (58 ATTTC) and selected non-pathogenic repeats were tested; RBP sequestration mechanisms are inferred from in silico, in vitro, and preprint data rather than directly demonstrated in this study.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig. 3. Pathogenic (AUUUC)58 RNA induces developmental defects in PMN axons and AChR distribution in zebrafish muscle. (A) Schematic of the analyzed region in zebrafish, depicting 24-hpf primary motor neuron (PMN) axons, innervating muscle cells where acetylcholine receptors (AChRs) are localized. (B) Top: Representative z-average projections of PMNs axons in embryos microinjected with vehicle, non-pathogenic (AUUUU)7 or pathogenic (AUUUC)58 RNAs in the six-somite region anterior to the cloaca (scale bars: 50 µm). Bottom: Quantification of PMN axon lengths in the described embryos [vehicle and (AUUUU)7: n=16: (AUUUC)58: n=18; three replicates; **P<0.01 and ***P<0.001, Kruskal–Wallis with Dunn's post-hoc test]. (C) Representative z-maximum projections of neuromuscular junctions (NMJs) in the four-somite-spanning region anterior to the cloaca (scale bars: 50 µm). (D) Plot showing the AChR signal distribution along the dorsal-ventral muscle axis in the above-described embryos [vehicle and (AUUUU)7: n=19 and (AUUUC)58: n=21; three replicates; *P<0.05 and **P<0.01, one-way ANOVA with Bonferroni correction]. (E) Quantification of NMJ area [vehicle and (AUUUU)7: n=19, (AUUUC)58: n=21; three replicates; **P<0.01, one-way ANOVA with Bonferroni correction]. Data are presented as the mean+standard deviation.](https://figures.cochat.ai/paper-figures/1a112c32233f40a599d9e7d635886b6b/embryonic-spinocerebellar-ataxia-type-37-associated-auuuc-repeat-rna-causes-figure-3.jpg)

![Fig. 5. (AUUUC)58-injected zebrafish exhibit hyperactive coiling behavior. (A) Schematic of involuntary tail movement of 24 hpf zebrafish embryos. (B) Number of tail coils within 60 seconds by zebrafish embryos at 24 hpf [vehicle and (AUUUU)7: n=112, (AUUUC)58: n=82; seven replicates; *P<0.05 and **P<0.01, Kruskal–Wallis with Dunn's post-hoc test]. (C) Percentage of mobile and immobile larvae during a 10-min spontaneous locomotor test at 144 hpf [vehicle: n=55, (AUUUU)7: n=58, (AUUUC)58: n=57; three replicates; χ2 test]. (D) Total swimming distance of zebrafish larvae at 144 hpf [vehicle: n=35, (AUUUU)7: n=36, (AUUUC)58: n=41; three replicates; Kruskal–Wallis test]. (E) Time spent immobile by zebrafish larvae at 144 hpf [vehicle: n=35, (AUUUU)7: n=36, (AUUUC)58: n=41; three replicates; Kruskal–Wallis test]. (F) Number of immobility episodes in larvae at 144 hpf, i.e. immobile for ≥2 s [vehicle: n=35, (AUUUU)7: n=36, (AUUUC)58: n=41; three replicates; *P<0.05, Kruskal–Wallis with Dunn's post-hoc test). Data are presented as the mean+standard deviation.](https://figures.cochat.ai/paper-figures/49891d845d344133b076582fe7fc71f3/embryonic-spinocerebellar-ataxia-type-37-associated-auuuc-repeat-rna-causes-figure-5.jpg)
![Fig. 6. Pathogenic (AUUUC)58 causes motor impairment in late-adult zebrafish at 17 months and negatively affects motor performance in fish aged 3 to 17 months. (A-C) Novel diving tank test conducted on microinjected animals at 17 months [vehicle and (AUUUU)7: n=20, (AUUUC)58: n=19]. Percentage of immobile animals (Kruskal–Wallis test) (A). Total swimming distance (*P<0.05 and **P<0.01, two-way ANOVA with condition and sex as factors) (B). Average swimming speed (*P<0.05 and ***P<0.001, two-way ANOVA with condition and sex as factors) (C). (D-F) Novel diving tank test performed with animals aged 3 months (n=14 animals per condition) and 17 months [vehicle and (AUUUU)7: n=20, (AUUUC)58: n=19]. Percentage of immobile animals (Mann–Whitney U-test) (D). Total swimming distance (**P<0.01 and ****P<0.0001, two-way ANOVA with condition and age as factors) (E). Average swimming speed while animals are active (***P<0.001 and ****P<0.0001, two-way ANOVA with condition and age as factors) (F). Data are shown as the mean+standard deviation.](https://figures.cochat.ai/paper-figures/f26236e271214ea6bf4526d78377d6de/embryonic-spinocerebellar-ataxia-type-37-associated-auuuc-repeat-rna-causes-figure-6.jpg)
![Fig. 7. NOVA2 mitigates axonal defects caused by pathogenic (AUUUC)58 RNA in zebrafish PMNs. (A) Maximum z-scores of putative RNA-binding proteins (RBPs) that bind non-pathogenic (AUUUU)199 or pathogenic (AUUUC)58 RNA, assessed by using the RBPmap tool (P<0.05). (B) Average z-score for each binding site for NOVA1 within (AUUUU)199 or (AUUUC)58 RNA. Data are shown as the mean+standard deviation. (C) Representative z-average projections of zebrafish primary motor neuron (PMN) axons in the six-somite region anterior to the cloaca at 24 hpf (scale bars: 50 µm). (D) Length of PMN axons in embryos microinjected with either vehicle, NOVA2 (NOVA2), (AUUUU)7, (AUUUC)58, or a combination of (AUUUC)58 and NOVA2 [(AUUUC)58 +NOVA2] mRNA (n=30 embryos per condition; three replicates; *P<0.05, ***P<0.001 and ****P<0.0001, two-way ANOVA with conditions and replicates as factors, followed by Bonferroni post-hoc test for axon length, after applying a cube root data transformation). Raw data are represented as the mean+standard deviation. (E) Z-projection images showing the nuclear and cytoplasmic distribution of human NOVA2 in 24 hpf zebrafish muscle after NOVA2 mRNA microinjection. Representative z-maximum projections with (left) and without (right) anti-histidine primary antibody (white). Nuclei were stained with DAPI (purple). Scale bars: 5 µm.](https://figures.cochat.ai/paper-figures/12bd94f4fd73423089b1f19a356826b7/embryonic-spinocerebellar-ataxia-type-37-associated-auuuc-repeat-rna-causes-figure-7.jpg)

Verification
Claims the paper makes
0 Valid · 0 Not valid · 73 Not checked · 119 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We detected decreased α-BTX fluorescence intensity in (AUUUC)58 larvae (1475±1403 a.u.) compared with (AUUUU)7 larvae at 72 hpf (2559±1678 a.u.; P=0.034)”
§ Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects > RESULTS > The SCA37-associated (AUUUC)58 RNA impairs axonal growth and dorsal-ventral neuromuscular innervation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Importantly, morphological defects were detected only in GFP-positive embryos”
§ Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects > RESULTS > The pathogenic (AUUUC)58 RNA induces developmental defects in zebrafish
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These results demonstrated that the average number of AChRs by area is not different in the dorsal-ventral axis across conditions”
§ Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects > RESULTS > The SCA37-associated (AUUUC)58 RNA impairs axonal growth and dorsal-ventral neuromuscular innervation
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We observed a significant increase in tail coiling in embryos microinjected with the (AUUUC)58 RNA (5±6 coils) compared with those microinjected with non-pathogenic (AUUUU)7 RNA (3±2 coils, P=0.043) or vehicle controls (3±2 coils, P=0.003)”
§ Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects > RESULTS > The pathogenic (AUUUC)58 RNA disrupts spontaneous early motor activity
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We measured the length of PMN axons in 24 hpf zebrafish embryos and observed significantly shorter axons in (AUUUC)58-injected embryos (27±8 µm) compared with embryos microinjected with the non-pathogenic (AUUUU)7 RNA (43±12 μm, P=0.0003) or vehicle control (40±11 µm, P=0.004)”
§ Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects > RESULTS > The SCA37-associated (AUUUC)58 RNA impairs axonal growth and dorsal-ventral neuromuscular innervation
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
90 more claims
Create a free account to see all 192 claims and to verify the 102 references still open.
- The quote only partly states this claim. 3
- It may state two separate claims as one. 46
- Probably not a substantial claim. 57
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects > RESULTS > Transient expression of the SCA37-associated (AUUUC)58 RNA in early zebrafish development alters locomotor profile in adulthood
“zebrafish microinjected with pathogenic (AUUUC)58 RNA exhibited a significant shorter swimming distance (28±9 m) and reduced speed (9±2 cm/s)”
§ Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects > RESULTS > Transient expression of the SCA37-associated (AUUUC)58 RNA in early zebrafish development alters locomotor profile in adulthood
“v3mth=8±1 cm/s and v17mth=8±2 cm/s”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects > RESULTS > The pathogenic (AUUUC)58 RNA disrupts spontaneous early motor activity
“does not have a direct effect later, at 144 hpf”
§ Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects > RESULTS > The pathogenic (AUUUC)58 RNA disrupts spontaneous early motor activity
“larvae microinjected with the pathogenic (AUUUC)58 RNA exhibited an increased number of immobility episodes (33±30 episodes) compared with vehicle controls (14±16 episodes, P=0.02)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects > RESULTS > Transient expression of the SCA37-associated (AUUUC)58 RNA in early zebrafish development alters locomotor profile in adulthood
“percentage of time spent immobile across conditions [vehicle: 6±4%; (AUUUU)7: 7±6%; (AUUUC)58: 9±10%] (Fig. 6A)”
§ Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects > RESULTS > Transient expression of the SCA37-associated (AUUUC)58 RNA in early zebrafish development alters locomotor profile in adulthood
“Percentage of immobile animals (Kruskal–Wallis test) (A).”
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Stages of embryonic development of the zebrafish
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B., & Schilling, T. F. (1995) · Developmental Dynamics · doi:10.1002/aja.1002030302 · Cited by 12,037
QuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
A protein related to extracellular matrix proteins deleted in the mouse mutant reeler
D'Arcangelo, G., G. Miao, G., Chen, S.-C., Scares, H. D., Morgan, J. I., & Curran, T. (1995) · Nature · doi:10.1038/374719a0 · Cited by 1,748
Computer Control of Microscopes Using µManager
Edelstein, A., Amodaj, N., Hoover, K., Vale, R., & Stuurman, N. (2010) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb1420s92 · Cited by 1,670
Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images
Meijering, E., Jacob, M., Sarria, J. ‐. F., Steiner, P., Hirling, H., & Unser, M. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20022 · Cited by 1,608
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., & Herz, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80782-5 · Cited by 1,261
Klockgether, T., Mariotti, C., & Paulson, H. L. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0074-3 · Cited by 696
Neuronal position in the developing brain is regulated by mouse disabled-1
Howell, B. W., Hawkes, R., Soriano, P., & Cooper, J. A. (1997) · Nature · doi:10.1038/39607 · Cited by 692 · cited 2×
“…adaptor protein DAB1 that is known to have an important role in neurodevelopment, including neuronal migration, brain layer organization and axonal pathfinding (Beffert et al., 2002; D ’ Arcangelo et al., 1995; Howell et al., 1997; Rice et al., 1998; Sheldon et al., 1997; Trommsdorff et al., 1999).”
Scrambler and yotari disrupt the disabled gene and produce a reeler -like phenotype in mice
Sheldon, M., Rice, D. S., D'Arcangelo, G., Yoneshima, H., Nakajima, K., Mikoshiba, K., Howell, B. W., Cooper, J. A., Goldowitz, D., & Curran, T. (1997) · Nature · doi:10.1038/39601 · Cited by 638 · cited 2×
“…adaptor protein DAB1 that is known to have an important role in neurodevelopment, including neuronal migration, brain layer organization and axonal pathfinding (Beffert et al., 2002; D ’ Arcangelo et al., 1995; Howell et al., 1997; Rice et al., 1998; Sheldon et al., 1997; Trommsdorff et al., 1999).”
RBPmap: a web server for mapping binding sites of RNA-binding proteins
Paz, I., Kosti, I., Ares, M., Cline, M., & Mandel-Gutfreund, Y. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku406 · Cited by 579
Rice, D. S., Sheldon, M., D’Arcangelo, G., Nakajima, K., Goldowitz, D., & Curran, T. (1998) · Development · doi:10.1242/dev.125.18.3719 · Cited by 378
Development of the locomotor network in zebrafish
Drapeau, P., Saint-Amant, L., Buss, R. R., Chong, M., McDearmid, J. R., & Brustein, E. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00075-8 · Cited by 376
Reelin, Rap1 and N-cadherin orient the migration of multipolar neurons in the developing neocortex
Jossin, Y., & Cooper, J. A. (2011) · Nature Neuroscience · doi:10.1038/nn.2816 · Cited by 332
Huntington’s disease alters human neurodevelopment
Barnat, M., Capizzi, M., Aparicio, E., Boluda, S., Wennagel, D., Kacher, R., Kassem, R., Lenoir, S., Agasse, F., Braz, B. Y., et al. (2020) · Science · doi:10.1126/science.aax3338 · Cited by 326 · cited 2×
“…support findings that expression of pathological expanded repeats during embryonic development disrupts neural cell progenitor differentiation and neuronal connectivity, setting the stage for adult-onset neurodegeneration (Barnat et al., 2020; Hickman et al., 2021; Shabani and Hassan, 2023).”
Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy
Ishiura, H., Doi, K., Mitsui, J., Yoshimura, J., Matsukawa, M. K., Fujiyama, A., Toyoshima, Y., Kakita, A., Takahashi, H., Suzuki, Y., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0067-2 · Cited by 319
IVA cloning: A single-tube universal cloning system exploiting bacterial In Vivo Assembly
García-Nafría, J., Watson, J. F., & Greger, I. H. (2016) · Scientific Reports · doi:10.1038/srep27459 · Cited by 311
Reelin-mediated Signaling Locally Regulates Protein Kinase B/Akt and Glycogen Synthase Kinase 3β
Beffert, U., Morfini, G., Bock, H. H., Reyna, H., Brady, S. T., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209205200 · Cited by 306
Anatomy of zebrafish cerebellum and screen for mutations affecting its development
Bae, Y.-K., Kani, S., Shimizu, T., Tanabe, K., Nojima, H., Kimura, Y., Higashijima, S.-I., & Hibi, M. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.04.013 · Cited by 293
Recovery from Polyglutamine-Induced Neurodegeneration in Conditional SCA1 Transgenic Mice
Zu, T., Duvick, L. A., Kaytor, M. D., Berlinger, M. S., Zoghbi, H. Y., Clark, H. B., & Orr, H. T. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2978-04.2004 · Cited by 262
RORα-Mediated Purkinje Cell Development Determines Disease Severity in Adult SCA1 Mice
Serra, H. G., Duvick, L., Zu, T., Carlson, K., Stevens, S., Jorgensen, N., Lysholm, A., Burright, E., Zoghbi, H. Y., Clark, H. B., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.036 · Cited by 234
Nova2 Regulates Neuronal Migration through an RNA Switch in Disabled-1 Signaling
Yano, M., Hayakawa-Yano, Y., Mele, A., & Darnell, R. B. (2010) · Neuron · doi:10.1016/j.neuron.2010.05.007 · Cited by 176
Machado–Joseph disease/spinocerebellar ataxia type 3
(2012) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-51892-7.00027-9 · Cited by 169
Florian, R. T., Kraft, F., Leitão, E., Kaya, S., Klebe, S., Magnin, E., van Rootselaar, A.-F., Buratti, J., Kühnel, T., Schröder, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12763-9 · Cited by 164
Corbett, M. A., Kroes, T., Veneziano, L., Bennett, M. F., Florian, R., Schneider, A. L., Coppola, A., Licchetta, L., Franceschetti, S., Suppa, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12671-y · Cited by 157
Proneural gene-linked neurogenesis in zebrafish cerebellum
Kani, S., Bae, Y.-K., Shimizu, T., Tanabe, K., Satou, C., Parsons, M. J., Scott, E., Higashijima, S.-I., & Hibi, M. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.03.024 · Cited by 156
Seixas, A. I., Loureiro, J. R., Costa, C., Ordóñez-Ugalde, A., Marcelino, H., Oliveira, C. L., Loureiro, J. L., Dhingra, A., Brandão, E., Cruz, V. T., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.06.007 · Cited by 152
Self-citationIshiguro, T., Sato, N., Ueyama, M., Fujikake, N., Sellier, C., Kanegami, A., Tokuda, E., Zamiri, B., Gall-Duncan, T., Mirceta, M., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.046 · Cited by 138
Kanai, K. (2003) · Brain · doi:10.1093/brain/awg073 · Cited by 135
A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism
Swinnen, B., Bento-Abreu, A., Gendron, T. F., Boeynaems, S., Bogaert, E., Nuyts, R., Timmers, M., Scheveneels, W., Hersmus, N., Wang, J., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1796-5 · Cited by 133
NOVA2-mediated RNA regulation is required for axonal pathfinding during development
Saito, Y., Miranda-Rottmann, S., Ruggiu, M., Park, C. Y., Fak, J. J., Zhong, R., Duncan, J. S., Fabella, B. A., Junge, H. J., Chen, Z., et al. (2016) · eLife · doi:10.7554/elife.14371 · Cited by 128
TTTCA repeat insertions in an intron of YEATS2 in benign adult familial myoclonic epilepsy type 4
Yeetong, P., Pongpanich, M., Srichomthong, C., Assawapitaksakul, A., Shotelersuk, V., Tantirukdham, N., Chunharas, C., Suphapeetiporn, K., & Shotelersuk, V. (2019) · Brain · doi:10.1093/brain/awz267 · Cited by 126
White, M. C., Gao, R., Xu, W., Mandal, S. M., Lim, J. G., Hazra, T. K., Wakamiya, M., Edwards, S. F., Raskin, S., Teive, H. A. G., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000984 · Cited by 115
Ruggiu, M., Herbst, R., Kim, N., Jevsek, M., Fak, J. J., Mann, M. A., Fischbach, G., Burden, S. J., & Darnell, R. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813112106 · Cited by 113
Spinocerebellar ataxia type 2 (SCA 2) in an infant with extreme CAG repeat expansion
Babovic‐Vuksanovic, D., Snow, K., Patterson, M. C., & Michels, V. V. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19981012)79:5<383::aid-ajmg10>3.0.co;2-n · Cited by 109
Neuromuscular synaptogenesis in wild-type and mutant zebrafish
Panzer, J. A., Gibbs, S. M., Dosch, R., Wagner, D., Mullins, M. C., Granato, M., & Balice-Gordon, R. J. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.06.027 · Cited by 106
‘Costa da Morte’ ataxia is spinocerebellar ataxia 36: clinical and genetic characterization
García-Murias, M., Quintáns, B., Arias, M., Seixas, A. I., Cacheiro, P., Tarrío, R., Pardo, J., Millán, M. J., Arias-Rivas, S., Blanco-Arias, P., et al. (2012) · Brain · doi:10.1093/brain/aws069 · Cited by 100
Self-citationAlonso, I. D. C. M. P., Barros, J., Tuna, A., Coelho, J., Sequeiros, J., Silveira, I., & Coutinho, P. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.610 · Cited by 100
Self-citationClinical features of SCA36: a novel spinocerebellar ataxia with motor neuron involvement (Asidan)
Ikeda, Y., Ohta, Y., Kobayashi, H., Okamoto, M., Takamatsu, K., Ota, T., Manabe, Y., Okamoto, K., Koizumi, A., & Abe, K. (2012) · Neurology · doi:10.1212/wnl.0b013e318260436f · Cited by 96
Miyamoto, Y., Yamauchi, J., Sanbe, A., & Tanoue, A. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.11.017 · Cited by 95 · cited 1×
“…al., 2015), including transcripts encoding the cytoskeleton proteins Dock6, Rap1Gap and DBS that are, respectively, involved in neuronal processes, such as neurite outgrowth (Miyamoto et al., 2007), neuronal migration (Jossin and Cooper, 2011) and stabilization of synapses (Hayashi et al., 2013).”
Evolution of Nova-Dependent Splicing Regulation in the Brain
Jelen, N., Ule, J., Živin, M., & Darnell, R. B. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030173 · Cited by 92
Lannoo, M. J., Brochu, G., Maler, L., & Hawkes, R. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903100207 · Cited by 83
Capizzi, M., Carpentier, R., Denarier, E., Adrait, A., Kassem, R., Mapelli, M., Couté, Y., & Humbert, S. (2022) · Neuron · doi:10.1016/j.neuron.2021.10.033 · Cited by 82
Saito, Y., Yuan, Y., Zucker-Scharff, I., Fak, J. J., Jereb, S., Tajima, Y., Licatalosi, D. D., & Darnell, R. B. (2019) · Neuron · doi:10.1016/j.neuron.2018.12.019 · Cited by 77
Lannoo, M. J., Ross, L. R., Maler, L., & Hawkes, R. B. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90022-s · Cited by 75
Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1
Edamakanti, C. R., Do, J., Didonna, A., Martina, M., & Opal, P. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96765 · Cited by 69
Ebner, B. A., Ingram, M. A., Barnes, J. A., Duvick, L. A., Frisch, J. L., Clark, H. B., Zoghbi, H. Y., Ebner, T. J., & Orr, H. T. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.6311-11.2013 · Cited by 63
Hayashi, T., Yoshida, T., Ra, M., Taguchi, R., & Mishina, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066254 · Cited by 62
Naganawa, Y., & Hirata, H. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.04.027 · Cited by 59
The alternative splicing factor Nova2 regulates vascular development and lumen formation
Giampietro, C., Deflorian, G., Gallo, S., Di Matteo, A., Pradella, D., Bonomi, S., Belloni, E., Nyqvist, D., Quaranta, V., Confalonieri, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9479 · Cited by 57
Advances in repeat expansion diseases and a new concept of repeat motif-phenotype correlation
Ishiura, H., & Tsuji, S. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.05.029 · Cited by 54
Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37
Corral-Juan, M., Serrano-Munuera, C., Rábano, A., Cota-González, D., Segarra-Roca, A., Ispierto, L., Cano-Orgaz, A. T., Adarmes, A. D., Méndez-del-Barrio, C., Jesús, S., et al. (2018) · Brain · doi:10.1093/brain/awy137 · Cited by 53
Diving deeper into Zebrafish development of social behavior: Analyzing high resolution data
Buske, C., & Gerlai, R. T. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.06.019 · Cited by 51
Mattioli, F., Hayot, G., Drouot, N., Isidor, B., Courraud, J., Hinckelmann, M.-V., Mau-Them, F. T., Sellier, C., Goldman, A., Telegrafi, A., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.02.013 · Cited by 42
Hickman, R. A., Faust, P. L., Rosenblum, M. K., Marder, K., Mehler, M. F., & Vonsattel, J. P. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02269-4 · Cited by 42
The brain on time: links between development and neurodegeneration
Shabani, K., & Hassan, B. A. (2023) · Development · doi:10.1242/dev.200397 · Cited by 41
Alonso, I. D. C. M. P., Barros, J., Tuna, A., Seixas, A. I., Coutinho, P., Sequeiros, J., & Silveira, I. (2003) · Clinical Genetics · doi:10.1111/j..2004.00187.x · Cited by 41
Self-citationTorres, C. A. M., Zafar, F., Tsai, Y., Vazquez, J. P., Gallagher, M. D., McLaughlin, I. J., Hong, K., Lai, J., Lee, J., Chirino‐Pérez, A., et al. (2022) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2022.100137 · Cited by 39
Pentanucleotide Repeat Insertions in RAI1 Cause Benign Adult Familial Myoclonic Epilepsy Type 8
Yeetong, P., Dembélé, M. E., Pongpanich, M., Cissé, L., Srichomthong, C., Maīga, A. B., Dembélé, K., Assawapitaksakul, A., Bamba, S., Yalcouyé, A., et al. (2023) · Movement Disorders · doi:10.1002/mds.29654 · Cited by 32
Todd, P. K., Ackall, F. Y., Hur, J., Sharma, K., Paulson, H. L., & Dowling, J. J. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012427 · Cited by 31
Molecular mechanisms in pentanucleotide repeat diseases
Loureiro, J. R., Castro, A. F., Figueiredo, A. S., & Silveira, I. (2022) · Cells · doi:10.3390/cells11020205 · Cited by 28
Self-citationCACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraine
Stam, A., Vanmolkot, K., Kremer, H., Gärtner, J., Brown, J., Leshinsky‐Silver, E., Gilad, R., Kors, E., Frankhuizen, W., Ginjaar, H., et al. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.00996.x · Cited by 26
Simultaneous ALS and SCA2 associated with an intermediate-length ATXN2 CAG-repeat expansion
Ghahremani Nezhad, H., Franklin, J. P., Alix, J. J. P., Moll, T., Pattrick, M., Cooper-Knock, J., Shanmugarajah, P., Beauchamp, N. J., Hadjivissiliou, M., Paling, D., et al. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1853172 · Cited by 24
Issa, F. A., Mock, A. F., Sagasti, A., & Papazian, D. M. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010157 · Cited by 19
Bartelt, L. C., Switonski, P. M., Adamek, G., Longo, F., Carvalho, J., Duvick, L. A., Jarrah, S. I., McLoughlin, H. S., Scoles, D. R., Pulst, S. M., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adn5449 · Cited by 17
Hsieh, J.-Y., Ulrich, B. N., Issa, F. A., Lin, M.-C. A., Brown, B., & Papazian, D. M. (2020) · eLife · doi:10.7554/elife.57358 · Cited by 17
Scala, M., Drouot, N., MacLennan, S. C., Wessels, M. W., Krygier, M., Pavinato, L., Telegrafi, A., de Man, S. A., van Slegtenhorst, M., Iacomino, M., et al. (2022) · Human Mutation · doi:10.1002/humu.24414 · Cited by 16
Rosenbohm, A., Pott, H., Thomsen, M., Rafehi, H., Kaya, S., Szymczak, S., Volk, A. E., Mueller, K., Silveira, I., Weishaupt, J. H., et al. (2022) · Movement Disorders · doi:10.1002/mds.29221 · Cited by 16
Self-citationMechanistic and therapeutic insights into ataxic disorders with pentanucleotide expansions
Zhang, N., & Ashizawa, T. (2022) · Cells · doi:10.3390/cells11091567 · Cited by 14
Characteristic evoked potentials in childhood-onset dentatorubral-pallidoluysian atrophy
Miyazaki, M., Hashimoto, T., Nakagawa, R., Yoneda, Y., Tayama, M., Kawano, N., Murayama, N., Kondo, I., & Kuroda, Y. (1996) · Brain and Development · doi:10.1016/0387-7604(96)00039-3 · Cited by 14
Pentanucleotide repeat‐related disorders: Genetics and bioinformatic discovery and detection
Silveira, I., & Bennett, M. F. (2023) · Epilepsia · doi:10.1111/epi.17593 · Cited by 4
Self-citationFigueiredo, A. S., Loureiro, J. R., Sampaio, P., Osório, H., Soler-López, M., Bessa, J., Bohic, S., Macedo-Ribeiro, S., & Silveira, I. (2025) · doi:10.1101/2025.09.03.673996 · Cited by 1
Self-citationLoureiro, J. R., Castro, A. F., Figueiredo, A. S., Eufrásio, A., Dhingra, A., Galhardo, M., Marcelino, H., Rodrigues, C. C., Sampaio, P., Azevedo, M., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117146 · Cited by 1
Self-citation
Cited by
Figueiredo, A. S., Loureiro, J. R., Sampaio, P., Osório, H., Soler-López, M., Bessa, J., Bohic, S., Macedo-Ribeiro, S., & Silveira, I. (2025) · doi:10.1101/2025.09.03.673996 · Cited by 1
Self-citationFamilial adult myoclonus epilepy (FAME)
Coppola, A., Depienne, C., & van Rootselaar, A. (2026) · International review of movement disorders · doi:10.1016/bs.irmvd.2026.07.001
First person – Ana Filipa Castro
(2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052960
Metadata
- Authors
- Castro, A. F., Figueiredo, A. S., Loureiro, J. R., Azevedo, M. M., Sampaio, P., Valentim, A. M., Bessa, J., & Silveira, I.
- Affiliations
- Universidade do Porto (PT)
- Corresponding author
- Silveira, Isabel
- ORCID
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2026-04-01
- Volume
- 19
- Issue
- 4
- ISSN
- 1754-8403 (ISSN-L)
- 1754-8411
- PMC
- PMC13225218
- OpenAlex
- W7138846058
- Cited by
- 3
- References
- 74
- Citations by year
- 2026: 2
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Disease Models & Mechanisms (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Fundação para a Ciência e a Tecnologia
- the European Regional Development Fund; COMPETE2030 and Fundação para a Ciência e a Tecnologia
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- Dab1, neurodevelopmental defects, axon growth, motor neuron innervation, muscle innervation, motor impairment, NOVA2, splicing regulation, zebrafish model, neurodegeneration
- MeSH terms
- Neuro-Oncological Ventral Antigen, Neurodevelopment, Animals, Axons, Disease Models, Animal, Embryo, Nonmammalian, Motor Activity, Motor Neurons, Muscles, Nerve Tissue Proteins, Phenotype, RNA, Synapses, Zebrafish, RNA-Binding Proteins, Spinocerebellar Ataxias, Zebrafish Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.